Photo taken from NCI Division of Cancer Prevention/LinkedIn
Aug 2, 2024, 05:24
NCI Cancer Currents Blog about FDA’s recent approvals of self-collection devices for HPV
NCI Division of Cancer Prevention shared on LinkedIn:
“Check out the latest National Cancer Institute (NCI) Cancer Currents Blog featuring DCP’s Vikrant Sahasrabuddhe.
He talks about how the FDA’s recent expanded approvals of self-collection devices for HPV screening relate to the recently launched SHIP (Self-collection for HPV testing to Improve Cervical Cancer Prevention) Trial.
Read the blog.
Learn more about SHIP and NCI’s Last Mile Initiative.”
